Eyenovia acquires US licencing rights for Formosa’s topical eye steroid
Eyenovia hopes for near-term revenue from the licencing deal, with APP13007’s PDUFA date set for 4 March 2024.
Eyenovia hopes for near-term revenue from the licencing deal, with APP13007’s PDUFA date set for 4 March 2024.
What's Your Reaction?
